Peptides MedCenter is the independent resource for understanding, researching, and working with bioactive peptides. From molecular data and synthesis chemistry to reconstitution protocols and dosage calculations — everything in one place.
Bioactive peptides are short chains of amino acids — typically between two and fifty residues long — linked together by covalent peptide bonds. Unlike larger proteins, peptides possess higher target specificity, lower immunogenic potential, and more predictable pharmacokinetic profiles, making them exceptionally valuable subjects for modern biochemical research.
The peptide research landscape has shifted dramatically in recent years. What began as a niche area of laboratory investigation has become one of the fastest-growing frontiers in biochemical science. Sequences like BPC-157, Semaglutide, and TB-500 have moved from early-stage curiosity to widely studied compounds with significant bodies of published research behind them.
Peptides MedCenter was built to bridge the gap between abstract research data and the practical needs of the research community. Every peptide documented here includes its primary mechanism of action, theoretical molecular weight, accepted purity benchmarks, and the research applications it is most commonly associated with.
The covalent bond formed between the carboxyl group of one amino acid and the amino group of another. This bond is the structural backbone of every peptide chain.
Freeze-drying process used to preserve peptide integrity. Removes water content while maintaining molecular structure, resulting in a stable powder form for long-term storage.
High-Performance Liquid Chromatography measures a peptide’s purity by separating sample components. A single dominant peak with a clean baseline indicates research-grade quality above 98.5%.
The mass of a peptide molecule measured in grams per mole. Confirmed via Mass Spectrometry — a mismatch between theoretical and measured MW indicates mislabelling or synthesis errors.
Every sequence below is documented with its primary mechanism, research application, and the category of study it is most commonly associated with.
Peptides primarily studied for appetite regulation, fat metabolism, and metabolic homeostasis.
GLP-1 receptor agonist. Suppresses appetite and slows gastric emptying. Active ingredient in Ozempic® and Wegovy®. One of the most widely researched weight-loss peptides in existence.
Dual GLP-1 / GIP agonist delivering top-tier metabolic effects. Active ingredient in Mounjaro® and Zepbound®. Represents the next generation of metabolic research compounds.
Isolated fragment of human growth hormone engineered specifically to stimulate lipolysis — the breakdown of stored fat — without affecting blood glucose levels or insulin sensitivity.
Synthetic GHRH analog that selectively reduces visceral adipose tissue. Particularly studied for its effects on abdominal fat deposits while preserving lean muscle mass.
Emerging triple-agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Early-stage research showing advanced efficacy profiles for fat loss and glucose regulation.
Peptides studied for tissue repair, growth hormone stimulation, and accelerated recovery from injury or exercise.
Gastric-stable pentadecapeptide derived from human gastric juice. Extensively researched for tendon repair, ligament healing, muscle recovery, and gut health restoration.
Synthetic fragment of Thymosin Beta-4 containing the active Ac-SDKP domain. Promotes rapid tissue regeneration, reduces inflammation, and accelerates recovery from muscular injury.
Highly selective growth-hormone secretagogue with a clean side-effect profile. Commonly stacked with CJC-1295 to create sustained, physiologic GH release for muscle building.
Synthetic GHRH analog with an extended half-life. Produces sustained growth-hormone release, widely studied for promoting muscle growth, fat reduction, and recovery between training sessions.
Potent GH secretagogue among the strongest in its class. Researched for muscle growth, strength enhancement, and cardioprotective effects independent of its GH-stimulating activity.
Long R3 variant of Insulin-like Growth Factor 1. Directly stimulates muscle cell proliferation and hyperplasia — the creation of new muscle fibres — rather than just increasing fibre size.
Growth Hormone Releasing Peptide-6. Amplifies natural GH pulses and is also studied for its appetite-stimulating properties and synergistic effects when combined with GHRH analogs.
Orally bioavailable GH secretagogue — technically a mimetic rather than a true peptide. Researched for lean-mass preservation, appetite stimulation, improved sleep architecture, and recovery.
Peptides with documented activity in collagen induction, tissue remodelling, and cellular skin repair.
Copper tripeptide complex. One of the most studied peptides in dermatological research for collagen induction, extracellular matrix remodelling, and accelerated wound healing at the cellular level.
Bioregulatory tetrapeptide that stimulates telomerase activity — the enzyme responsible for maintaining telomere length. Studied for cellular rejuvenation with notable documented effects on skin aging.
Melanocortin receptor agonist researched for skin pigmentation modulation. Also exhibits secondary effects on appetite regulation and has been studied across multiple metabolic pathways.
Melanocortin-based peptide primarily researched for sexual-function support via MC3 and MC4 receptor activity. Emerging research also explores its effects on vascular health and tissue repair.
Peptides studied for anti-aging mechanisms, immune modulation, and long-term cellular health.
Immune-system modulator with over three decades of clinical research history. Studied for infection resistance, hepatoprotection, and overall recovery support in long-term health protocols.
Bioidentical 29-amino-acid fragment of human GHRH. Frequently studied for anti-aging benefits including improved sleep architecture, natural GH stimulation, and enhanced recovery in aging populations.
Erythropoietin-derived peptide residues 11 through 33. Studied for neuropathic pain relief and cytoprotective mechanisms — specifically its ability to protect tissues from ischaemic damage.
Theoretical molecular weights and accepted purity thresholds for research-grade peptide sequences. Confirmed via HPLC and Mass Spectrometry.
| Sequence | Molecular Weight (g/mol) | Purity Benchmark | Primary Research Focus |
|---|---|---|---|
| BPC-157 | 1,419.53 | >99.0% | Angiogenesis / Tendon Repair |
| TB-500 (Tβ4) | 4,963.50 | >98.5% | Actin Sequestration / Tissue Migration |
| Semaglutide | 4,113.58 | >98.5% | GLP-1 Agonism / Appetite Regulation |
| Tirzepatide | 4,813.52 | >98.5% | Dual GLP-1/GIP / Metabolic Homeostasis |
| GHK-Cu | 340.38 | >99.5% | Collagen Induction / Skin Remodelling |
| Epitalon | 390.35 | >99.0% | Telomerase Activation / Anti-Aging |
| Ipamorelin | 711.86 | >99.0% | Selective GH Secretagogue |
| CJC-1295 | 3,357.42 | >98.5% | Sustained GH Release / Muscle Growth |
| Sermorelin | 3,357.55 | >98.5% | Bioidentical GHRH / Anti-Aging |
| AOD-9604 | 1,256.43 | >99.0% | Lipolysis / Fat Metabolism |
| Hexarelin | 887.01 | >99.0% | GH Secretion / Cardioprotection |
| IGF-1 LR3 | 9,110.00 | >98.0% | Muscle Hyperplasia / Direct Growth |
| Thymosin Alpha-1 | 3,888.06 | >99.0% | Immune Modulation / Recovery |
| Tesamorelin | 5,250.00 | >98.5% | Visceral Fat Reduction |
| PT-141 | 1,387.71 | >99.0% | Melanocortin / Sexual Function |
| Melanotan II | 1,024.19 | >99.0% | Pigmentation / Metabolic Effects |
| GHRP-6 | 820.10 | >98.5% | GH Pulse Amplification |
| MK-677 | 560.72 | >98.0% | Oral GH Secretagogue / Sleep |
| Retatrutide | ~4,800 | >98.5% | Triple Agonist / Advanced Fat Loss |
| ARA-290 | 2,580.00 | >99.0% | Neuropathic Pain / Cytoprotection |
Understanding synthesis and quality verification is essential for interpreting research data accurately.
High-quality research peptides are synthesised through Solid Phase Peptide Synthesis. In this method, the peptide chain is built upon an insoluble resin support. Each amino acid is added one at a time in sequence, with protecting groups — typically Fmoc or Boc — ensuring the coupling reaction occurs only at the intended terminus.
Each coupling step demands precise temperature control, exact timing, and exhaustive washing to remove residual reagents. Any failure in this process produces deletion sequences (a skipped amino acid) or truncated peptides (incomplete chains). These impurities are often undetectable without advanced chromatographic analysis but can fundamentally compromise research data integrity.
The choice of counter-ions — Acetate, TFA (Trifluoroacetic acid), or HCl — profoundly affects a peptide’s solubility and biological activity. TFA is common in the final cleavage stage of SPPS, but high residual levels are cytotoxic to cell cultures and can skew in-vitro results.
Research-grade peptides must undergo purification via Preparative HPLC to achieve purity above 98.5%. This step separates the target peptide from truncation byproducts, residual solvents, and counter-ion contamination. Batch-specific HPLC reports and Mass Spectrometry confirmation are the two non-negotiable certificates of quality for any legitimate research compound.
Correct handling is the difference between a compound that performs and one that degrades before it is used.
Freeze-dried peptide powder is most stable at −20°C to −80°C. At these temperatures, molecular vibration and hydrolytic degradation are effectively halted. Shelf life extends to 2 years or more when stored correctly.
Inject bacteriostatic water (0.9% benzyl alcohol) slowly along the inner wall of the vial. Never shake — swirl gently until the powder dissolves. Vigorous mechanical stress causes aggregation and loss of bioactivity.
Once reconstituted, store at 2°C to 8°C and use within 21 to 28 days. Avoid repeated freeze-thaw cycles. Some hydrophobic sequences require specific pH buffers based on their isoelectric point to remain in stable solution.
Need to calculate exact draw units for a reconstituted peptide? Our built-in dosage calculator handles single peptides, multi-peptide blends, custom syringe sizes, and all four solvent types. Every calculation runs to decimal-point precision.
Open Calculator →A research-grade peptide is synthesised to a purity of at least 98.5% and ships with batch-specific HPLC and Mass Spectrometry reports. It must be free from manufacturing contaminants, residual solvents like TFA, and structural deletions or truncation byproducts that would compromise experimental data.
Focus on the Area % column. This indicates the percentage of detected signal attributed to the main molecular peak. A high-quality sample shows a single dominant peak with a clean baseline — no secondary peaks or elevated noise. The Area % for the target compound should read 98.5% or above.
BPC-157 is a 15-amino-acid sequence derived from human gastric juice. Research indicates it maintains structural integrity in highly acidic environments (pH 1.0–2.0) that would degrade most other peptides. This gastric stability makes it a unique subject for studying oral bioavailability and gastrointestinal healing.
Thymosin Beta-4 (TB-4) is the full-length 43-amino-acid protein. TB-500 refers to the synthetic fragment — specifically the Ac-SDKP sequence — that contains the active domain responsible for the majority of TB-4’s regenerative research effects, including actin sequestration and cellular migration.
Lyophilised peptides should be stored at −20°C for up to 2 years or −80°C for extended timelines. Once reconstituted, refrigerate at 2°C to 8°C and use within 21 to 28 days. Avoid repeated freeze-thaw cycles, store in amber vials to prevent photo-oxidation, and never expose to mechanical stress.
Counter-ions (Acetate, TFA, or HCl) balance the charge on a peptide molecule and affect its solubility and biological behaviour. Residual TFA from the synthesis process is particularly problematic — it is cytotoxic at low concentrations and must be removed via preparative HPLC before a peptide qualifies as research-grade.
